Abstract Aims/hypothesis: The role of gamma-aminobutyric acid (GABA) and A-type GABA receptors (GABA A Rs) in modulating islet endocrine function has been actively investigated since the identification of GABA and GABA A Rs in the pancreatic islets. However, the reported effects of GABA A R activation on insulin secretion from islet beta cells have been controversial. Methods: This study examined the hypothesis that the effect of GABA on beta cell insulin secretion is dependent on glucose concentration. Results: Perforated patchclamp recordings in INS-1 cells demonstrated that GABA, at concentrations ranging from 1 to 1,000 μmol/l, induced a transmembrane current (I GABA ) which was sensitive to the GABA A R antagonist bicuculline. The current-voltage relationship revealed that I GABA reversed at −42±2.2 mV, independently of glucose concentration. Nevertheless, the glucose concentration critically controlled the membrane potential (V M ), i.e., at low glucose (0 or 2.8 mmol/l) the endogenous V M of INS-1 cells was below the I GABA reversal potential and at high glucose (16.7 or 28 mmol/l), the endogenous V M of INS-1 cells was above the I GABA reversal potential. Therefore, GABA dose-dependently induced membrane depolarisation at a low glucose concentration, but hyperpolarisation at a high glucose concentration. Consistent with electrophysiological findings, insulin secretion assays demonstrated that at 2.8 mmol/l glucose, GABA increased insulin secretion in a dose-dependent fashion (p<0.05, n=7). This enhancement was blocked by bicuculline (p<0.05, n=4). In contrast, in the presence of 28 mmol/l glucose, GABA suppressed the secretion of insulin (p<0.05, n=5). Conclusions/interpretation: These findings indicate that activation of GABA A Rs in beta cells regulates insulin secretion in concert with changes in glucose levels.
Introduction
Gamma-aminobutyric acid (GABA), which is synthesised from glutamic acid by the rate-limiting enzyme GAD, is a major inhibitory neurotransmitter in the mammalian central nervous system [1] . GABA induces rapid inhibition primarily by activating the A-type GABA receptor (GABA A R) [2] , a heteropentameric Cl -ion channels complex [3] . In most cases, activation of GABA A R in neurons results in membrane hyperpolarisation as a consequence of an inward Cl -flux [3] . The concentrations of GABA and GAD and the density of GABA A R in pancreatic islets are comparable with those encountered in the central nervous system [4] [5] [6] [7] [8] , suggesting that the GABA-GABA A R system plays a role in modulating islet endocrine functions. In the pancreas, GABA is primarily produced by insulin-secreting beta cells [9] [10] [11] and probably by the glucagon-containing alpha cells [9, 12] . GABA A Rs are expressed in both beta and alpha cells [13] [14] [15] , suggesting that GABA modulates pancreatic endocrine function in an autocrine and paracrine manner [16] [17] [18] . In pancreatic beta cells, GABA is associated with synaptic-like microvesicles that are distinct from the insulin-containing large dense-core vesicles [10, 11] . Release of GABA from beta cells appears to be regulated by nutrients [19] including glucose [19] [20] [21] .
The effect of GABA on insulin secretion from the beta cells has also been controversial. For example, perfusion studies using rat and dog pancreas have shown that GABA inhibits arginine-stimulated insulin release [16, 21] . Other studies demonstrate that both GABA and GABA A R agonists have no detectable effect on insulin secretion in perfused rat pancreas [22, 23] . However, GABA-induced increases in insulin release were observed in rat pancreas and isolated human insulinoma cells [13, 24, 25] .
The direction of the GABA A R-mediated Cl − current depends on membrane potential (V M ), which, in pancreatic beta cells, is critically regulated by extracellular glucose [26, 27] . We hypothesise that the effect of GABA on insulin secretion from beta cells is dependent on the extracellular glucose concentration. Using perforated patch-clamp recordings and insulin secretion assays, we examined in insulin-secreting INS-1 cells the effects of GABA on V M and insulin secretion in the presence of different levels of glucose. Our results indicate that, depending on the extracellular glucose levels, GABA can exert either excitatory or inhibitory effects on beta cells.
Materials and methods

Cell culture
INS-1 cells (passage 50-65) were maintained in RPMI 1640 medium (Invitrogen, Burlington, ON, Canada) containing fetal bovine serum (10% v/v), 100 Units/ml penicillin G sodium, 100 μg/ml streptomycin sulphate, 55 mg/500 ml sodium pyruvate, 1.14 g/500 ml HEPES, and 1.7 μl/500 ml β-mercaptoethanol at 37°C in an atmosphere of humidified air (95%) and CO 2 (5%). In studies involving serum-starvation, serum was replaced by 0.1% BSA in RPMI 1640 without glucose.
RT-PCR
Total cellular RNA was extracted from confluent 10-cm plates of INS-1 cells using Trizol (Invitrogen Life Technologies, CA, USA) following the manufacturer's instructions. GABA A R mRNA transcripts were detected using a one-step RT-PCR kit (Qiagen). Briefly, 100 ng total RNA were used in 25-μl one-step RT-PCR reactions containing 0.4 mmol/l dNTPs and 0.6 μmol/l of each primer. The template was omitted for the negative control. Thermocycler conditions were 50°C for 30 min, 95°C for 15 min, and 35 cycles at 94°C for 30 s, 60°C for 30 s, and 72°C for 1 min. This was followed by a 10-min extension at 72°C. The RT-PCR products were separated on a 1% agarose gel and visualised with ethidium bromide. The GABA A R gene-specific primers used were as follows: α1 FP: cgggaagaagctatggaca; α1 RP: ccactcatagacaacttctgc; α2 FP: tctagacagacttctggatgg; α2 RP: agagtcagaagcattg taagtc; α3 FP: cccagatattcctgacgatag; α3 RP: tgagccatcct gagctactt; β1 FP: cgactgctcaaaggatatgac; β1 RP: agtga tagtcgtggatatgcc; β2 FP: gctgtctgtgctcagagtgt; β2 RP: gtgactgcattgtcatcgcc; β3 FP: acggtcgacaagctgttgaa; β3 RP: tcgagcagcagatgcatc; γ1 FP: gtccagatataggcgtgaga; γ1 RP: ctccagtacttaggatcagc; γ2 FP: gcattggtccagtgaatgct; γ2 RP: ggaatgtaggtctggatggt; γ3 FP: acagcattggtcctgtgt ca; γ3 RP: caaactgatagagccgccat.
Immunoblotting
Cells were lysed in buffer containing 1% Triton X-100 and protease and phosphatase inhibitors, as previously described [28] . Proteins (50 μg) were separated by 10% SDS-PAGE and electrotransferred onto a nitrocellulose filter (0.2 μm; Bio-Rad Laboratories, Hercules, CA, USA). After probing with mouse anti-beta2/3 isoforms of GABA A R IgG (1:1,000; Upstate Biotechnology, Lake Placid, NY, USA), the proteins were visualised with horseradish peroxidase-conjugated goat anti-mouse IgG (1:5,000; Upstate Biotechnology) using an electrochemiluminescence detection technique (Amersham, Piscataway, NJ, USA), as described previously [28] .
Immunochemistry
Cells grown on glass coverslips in 12-well plates were fixed with paraformaldehyde (3.7% in PBS) and permeabilised with 0.2% Triton X-100. After incubation with 5% goat serum and 1% BSA (in PBS) for 60 min, cells were incubated with mouse antibodies against beta2/3 GABA A R subunits (1:100; Upstate Biotechnology) overnight at 4°C. After washing, cells were incubated with Cy3-conjugated goat anti-mouse IgG (1:500, 30 min; Jackson ImmunoResearch Laboratories, West Grove, PA, USA). Images were visualised using a Leica TCS 4D laser confocal fluorescence microscope.
Electrophysiology
Perforated patch recordings were performed at room temperature (23-25°C). One hour before recording, cells were bathed in the standard glucose-free extracellular solution containing (in mmol/l) 145 NaCl, 1.3 CaCl 2 , 5.4 KCl, 25 HEPES, (pH 7.4). Recordings were performed using an Axopatch-1D amplifier (Axon Instruments, Foster City, CA, USA). Electrodes (3-5 MΩ) were constructed from thin-walled glass (1.5 mm diameter; World Precision Instruments, Sarasota, FL, USA) using a two-stage puller (PP-830; Narishige, East Meadow, NY, USA). The standard intracellular solution for perforated patch recording consisted of (in mmol/l) 150 K-gluconate, 10 KCl, 10 KOH, 10 HEPES, 2 MgCl 2 and 1 CaCl 2 . After addition of the pore-forming agent amphotericin B (Sigma-Aldrich Corp., Buchs, Switzerland) [27] , the pH of the intracellular solution was adjusted to 7.30 (with KOH) and the osmolarity was corrected to a range of 310-315 mOsm.
Perforated recordings started under voltage-clamp mode. The effect of amphotericin B was observed as a constant decrease in serial resistance after the electrode seal. In most of the recordings, the resistance declined to a value ranging from 28 to 30 MΩ within 5-15 min after the seal, and then stabilised for 45-60 min. All perforated patch recordings began when the serial resistance had attained values below 28 MΩ. To monitor a possible formation of whole-cell configuration, a testing voltage-ramp (a gradual voltage change from -80 to 60 mV in 1.5 s) was applied to the cell at the start of recording, and approximately every 10 min during the recording. With this testing protocol, a sigmoidshaped current-voltage (I-V) curve was seen under stable perforated patch recordings, whereas a linear I-V relationship gradually appeared after whole-cell configuration. If a sudden change in the I-V relationship occurred, the recording was not used for the study. ] i ) was measured using Fura 2-AM (Molecular Probes). Cells grown on coverslips (70-80% confluency) were loaded with Fura-2 AM (3 μmol/l) in a medium containing (in mmol/l) 130 NaCl, 5 KCl, 2 CaCl 2 , 1 MgCl 2 , 5 NaHCO 3 and 10 HEPES, pH 7.4 for 50 min at 37°C. Cells were washed and transferred to an open chamber equipped with a TC-324B Heater Controller (Warner Instruments) and perfused with the same medium at 1 ml/min (36-37°C) while the recordings were made using an Olympus BX51W1 fluorescent microscope. Cells were excited by dual excitation at 340/380 nm using a DeltaRam high-speed monochromator (Photon Technology International) and the emissions were detected at 510 nm by a band pass filter. The system was equipped with ImageMaster 3 software for control of the monochromator, the video camera, and collecting data.
Insulin secretion
Insulin concentrations were measured using a rat insulin RIA kit (Linco Research, St. Louis, MO, USA) as previous described [28] . INS-1 cells grown in 24-well plates to 85-90% confluency were rinsed twice and incubated with KRB (containing, in mmol/l, 115 NaCl, 5 KCl, 24 NaHCO 3 , 2.5 CaCl 2 , 1 MgCl 2 , 10 HEPES, and 0.1% BSA) for Total RNA from INS-1 cells were used in one-step RT-PCR reactions using specific primers for the alpha 1-3 , beta [1] [2] [3] , and gamma [1] [2] [3] subunits to detect expression of the different subunits. In the control reaction, the template was omitted.
b Western blot on INS-1 cell lysates (50-μg protein) using a specific antibody against the beta 2/3 subunits of the GABA A R. COS cell lysates were used as control. c Immunocytochemistry of INS-1 cells using the antibody against beta 2/3 subunits of the GABA A R. COS cells were used in the control staining 60 min. Cells were incubated in KRB in the presence of various concentrations of glucose (dextrose; Merck KgaA, Darmstadt, Germany) and/or GABA (Sigma, St. Louis, MO, USA) as indicated. After 30 min of incubation, the media were collected and insulin levels measured by RIA using the rat insulin RIA kit according to the manufacturer's instructions. The insulin secretion was normalised to the cellular protein content. Protein was determined using the Bio-Rad protein assay kit (Bio-Rad Laboratories, CA, USA).
Statistical analysis
Data are expressed as means±SEM. For insulin secretion assays, the number of samples and separate experiments are described in the figure legends. Statistical difference between groups was analysed by ANOVA followed by a Student-Newman-Keuls test to estimate the differences between each pair of groups when applicable. For electrophysiological analysis, data were compared with Student's unpaired or paired t-test where appropriate. A p value <0.05 was considered as significant. Statistical analyses were performed using SigmaStat from Jandel Scientific Software (San Rafael, CA, USA).
Results
Expression of GAB A A receptor in INS-1 cells
RT-PCR experiments demonstrated that INS-1 cells express transcripts of GABA A R subunits alpha 1, alpha 2, alpha 3, beta 3 and gamma 3 (Fig. 1a) . It is known that in neurons, a functional GABA A R is usually a pentamer composed of two alpha, two beta and one gamma receptor subunits [2] . Thus, INS-1 cells appear to possess the necessary subunits for a functional GABA A R. Furthermore, Western blot analysis using a specific antibody directed against the beta2/3 subunits of GABA A R detected the expression of GABA A R proteins in INS-1 cells (Fig. 1b) . Expression and membrane localisation of GABA A R were also confirmed by immunostaining and confocal imaging studies (Fig. 1c) . In addition, immunostaining of rat pancreas sections using anti-alpha1 and beta2/3 subunit antibodies showed that islet beta cells express alpha1 and beta2 or beta 3 subunits (data not shown). To investigate whether the GABA A Rs in INS-1 cells were functional, we applied different concentrations of GABA to the cells by means of a fast perfusion system, and measured transmembrane currents using voltage-clamp recording techniques (Fig. 2a) . We found that when held at -60 mV, about 60% of cells generated visible inward currents in response to 1 μmol/l GABA. Yet, currents were generated in all tested cells when GABA concentrations were higher than 3 μmol/l. The GABA-induced currents were concentration-dependent (Fig. 2a,b) , with an EC 50 of 22.3 μmol/l (Fig. 2b) . We noticed that at lower concentrations of GABA (<30 μmol/l), the amplitude of the GABA-evoked current (I GABA ) was stable (not shown). However, at higher concentrations (>100 μmol/l), I GABA exhibited a rapid onset, characterised by a peak, followed by a gradual decay to a steady state (Fig. 2c, left) . In response to 100 μmol/l GABA, the peak amplitude of the I GABA in individual cells varied from 12 to 470 pA (Fig. 2d ) (control I GABA : 117±33 pA, n=15). Notably, I GABA could be reversibly suppressed by co-application of the competitive GABA A R antagonist, bicuculline (50 μmol/l; bicuculline I GABA : 7±2 pA, n=4; p<0.05) (Fig. 2d ). These results demonstrate that the GABA A Rs in INS-1 cells are physiologically functional.
We further characterised the I-V relationship of GABA A -R-gated channels in INS-1 cells. GABA (100 μmol/l) was applied to cells held at different V M levels (-80 to 40 mV, see Fig. 2e ) and the current was recorded. The plotted I-V curve indicated that in the absence of extracellular glucose, I GABA reversed at -42±2.2 mV (Fig. 2f, n=6) . Glucose is one of the key physiological regulators of beta cell functions. However, the reversal potential of I GABA in INS-1 cells was not affected by addition of 16.7 mmol/l glucose to the extracellular solution (Fig. 2g) , suggesting that glucose concentration does not affect this property of GABA A Rs, or the equilibrium potential of Cl -in INS-1 cells.
GABA regulates the excitability of INS-1 cells differently under different glucose concentrations
Glucose concentrations dictate the ratio of intracellular ATP/ADP concentrations, which in turn regulate the activity of ATP-sensitive K + (KATP) channels, thereby controlling the V M of beta cells [27, [29] [30] [31] . We tested the hypothesis that the level of glucose sets the instantaneous V M , which in turn determines the effect of GABA A R activation on the excitability of beta cells. Using currentclamp recordings, we measured the change in V M of INS-1 cells in response to increases of glucose concentration (0 to   2.8, 16.7 or 28 mmol/l, respectively, Fig. 3a) . In the absence of glucose, V M of INS-1 cells varied from −51 to −82 mV (Fig. 3b: −65±3 mV, n=12) . Increasing glucose concentrations depolarised the membrane of INS-1 cells in a concentration-dependent manner (Fig. 3a,b : V M at 2.8 mmol/l glucose: −53±2 mV; V M at 16.7 mmol/l: −32± 2 mV; V M at 28 mmol/l: −22±2 mV, n=6). In some cases, bursts of action potentials were seen during high-glucoseinduced depolarisation (Fig. 3a) .
Next, we examined the effect of different concentrations of GABA on V M at low and high concentrations of glucose (Fig. 3c) . GABA (1-1,000 μmol/l) induced membrane depolarisation as a function of dose in the absence of glucose, but caused membrane hyperpolarisation in the presence of 28 mmol/l glucose (Fig. 3c) . The EC 50 value of GABA on V M at low glucose was similar to that at high glucose (EC 50 at 0 mmol/l glucose: 24.4; EC 50 at 28 mmol/l glucose: 20.8 μmol/l, Fig. 3d,e) , suggesting that glucose does not affect the affinity of GABA for GABA A Rs. We further examined GABA (100 μmol/l)-induced changes in , 28 mmol/l). e Glucose-stimulated insulin secretion is concentration-dependent (n=4). Cells were incubated in KRB in the presence of various concentrations of glucose (Glu) as indicated. After 30 min of incubation, the media were collected and insulin levels were measured by RIA. f In the presence of 2.8 mmol/l glucose, insulin secretion was measured in the presence of different concentrations of GABA (n=7), with or without GABA A R antagonist bicuculline (Bic, 100 μmol/l, n=4). g Effect of GABA (100 μmol/l) and bicuculline (Bic, 100 μmol/l) on insulin secretion at 28 mmol/l glucose (Glu, n=4). *p<0.05, **p<0.01, ***p<0.005 V M at 0, 2.8, 16.8 and 28 mmol/l glucose, and confirmed that GABA could up-and downregulate the V M of beta cells in accordance with glucose concentrations (Fig. 3f , at 0 mmol/l glucose: depolarisation 12±1.2 mV, n=11; at 2.8 mmol/l: depolarisation 6.5±0.7 mV, n=9; at 16.8 mmol/l: hyperpolarisation -8.5±5 mV, n=9; at 28 mmol/l: hyperpolarisation -16.0±5 mV, n=9). (Fig. 4a,b, n=3 ; 30-50 cells were measured from each experiment). Perfusion of 28 mmol/l glucose led to a drastic increase in cytosolic Ca 2+ oscillation (Fig. 4c,d ). In this case, application of GABA (100μmol/l) suppressed the amplitude of Ca 2+ oscillation spikes (Fig. 4c,d) . Nevertheless, an increase in the frequency of Ca 2+ oscillation was observed in some cells (Fig. 4c) .
GABA increases
GABA-modulated insulin secretion in INS-1 cells is dependent on glucose concentration
Next, we determined whether GABA affects insulin secretion in INS-1 cells using insulin secretion assays. Glucose stimulated insulin secretion from INS-1 cells in a dose-dependent manner (Fig. 4e) . Consistent with the electrophysiological data, under low glucose conditions (2.8 mmol/l), GABA (1-1,000 μmol/l) steadily increased insulin secretion (Fig. 4f, p<0.05, n=7 ). This effect of GABA was significantly diminished by the GABA A R antagonist bicuculline (Fig. 4f, n=4) . In contrast, under high glucose conditions (28 mmol/l), GABA significantly suppressed insulin secretion (Fig. 4g, p<0.05, n=5 ). This suppression was also significantly attenuated by co-incubation of the cells with bicuculline (Fig. 4g, p<0.05, n=4) . Bicuculline, by itself, had no significant effect on insulin secretion under low and high glucose conditions (Fig. 4f,g,  p>0.05, n=4) . In contrast, the GABA B R agonist, baclofen had no significant effect on GABA-modulated insulin secretion from INS-1 cells at either low (2.8 mmol/l) or high (28 mmol/l) glucose (2.8 mmol/l: control vs. baclofen=1.0±0.1 vs. 0.98±0.09; 28 mmol/l: control vs. baclofen=1±0.16 vs. 1.12±0.19; p>0.05, n=3). These results indicate that activation of GABA A R up-and downregulates insulin secretion depending on the extracellular concentration of glucose.
Discussion
Previous studies [4] [5] [6] [7] [8] suggest that the pancreatic GABA-GABA A R system plays a role in modulating islet endocrine functions. However, the reported effects of GABA on insulin secretion from the beta cells have been controversial. In this study we demonstrated a mechanism by which GABA modulates insulin secretion from beta cells in concert with changes in glucose concentration.
We found that GABA A Rs are expressed in the widely used beta cell line INS-1 cells (Fig. 1) , which is consistent with previously reported studies in isolated human insulinoma cells [13] and rat pancreatic beta cells [15] . Since GABA is localised mainly within the pancreatic beta cells [32] , identification of GABA A Rs in the beta cells suggests that the GABA-GABA A R system may serve as both an autocrine and paracrine modulator in the islets. We also demonstrated that, dependent on dose, perfusion of GABA induced transmembrane currents in INS-1 cells, and that the GABA-induced current was sensitive to the GABA A R antagonist, bicuculline (Fig. 2a,c) . These results indicate that GABA A Rs in INS-1 cells are functional.
It is well known that by modulating the KATP conductance, glucose concentration critically sets the instantaneous V M of beta cells [27] . We confirmed that with increasing glucose concentrations, from 0 to 28 mmol/l, the V M of INS-1 cells changed from approximately −65 mV to approximately −22 mV. On the other hand, we found that changing glucose concentrations did not affect the reversal potential of GABA A R-mediated currents, which was at about −42 mV in INS-1 cells. Therefore, activation of GABA A R could potentially up-and downregulate the excitability of the cell, in accordance with changes in glucose concentrations. Indeed, our results demonstrated that while the cell membrane hyperpolarised in the presence of low glucose, application of GABA positively shifted the V M . In contrast, under conditions of high glucose, GABA negatively shifted the elevated V M . These data suggest that GABA, in concert with glucose, plays a role in regulation of excitability of the beta cell, thus regulating insulin secretion. This notion was strongly supported by the findings that GABA elevated the [Ca 2+ ] i . oscillations at low glucose (Fig. 4a) , but suppressed the amplitude of high-glucose-induced Ca 2+ -oscillation spikes (Fig. 4c) .
Our insulin RIA results further confirmed that GABA stimulated insulin secretion at low (2.8 mmol/l) glucose, but inhibited insulin secretion at high (28 mmol/l) glucose. The bi-directional regulation of insulin secretion in beta cells by GABA at different glucose levels implies an important role for GABA in modulating islet hormonal secretion. GABA, by modulating insulin secretion from beta cells in concert with changes in glucose concentration, provides a unique mechanism for pancreatic endocrine regulation. Notably, in the presence of low glucose (2.8 mmol/l), GABA caused a moderate but significant increase in insulin secretion (∼20-40%, equivalent to ∼0.3-0.4 nmol/l). Intracellular Ca 2+ measurements sug-gested that GABA-modulated insulin secretion in INS-1 cells may be via a mechanism involving Ca 2+ movement. Our findings in this study suggest that the GABA system may function as a negative feedback regulating mechanism in the islets. Under low glucose conditions, GABA release from beta cells increases [33, 34] , which in turn may enhance insulin secretion. It has been demonstrated that insulin is a physiological inhibitor of glucagon release within islets [35] under in vitro [36, 37] and in vivo [38] conditions. Studies on islet microvasculature have shown that the alpha cells lie downstream from the beta cells, thus insulin released from beta cells can immediately act on alpha cells [39] . Therefore, physiologically, a modest change in insulin concentrations in the islet could have a significant impact on glucagon secretion from alpha cells. For instance, when hypoglycaemia occurs, GABA-stimulated insulin may act on the alpha cells to prevent the potential hyperglycaemia resulting from excessive glucagon secretion, because glucagon is a prominent facilitator of glucose production [40, 41] . Likewise, during hyperglycaemia, GABA depresses insulin secretion thus preventing a potential hypoglycaemia resulting from insulin 'overshooting'.
